Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes.

[1]  D. Scherman,et al.  In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells. , 2010, Blood.

[2]  Hsin‐Lung Chen,et al.  Enhancement of efficiencies of the cellular uptake and gene silencing of chitosan/siRNA complexes via the inclusion of a negatively charged poly(γ-glutamic acid). , 2010, Biomaterials.

[3]  Udo Bakowsky,et al.  Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery. , 2010, Biomaterials.

[4]  S. Kawakami,et al.  Strategies for In Vivo Delivery of siRNAs , 2010, BioDrugs.

[5]  I. Toth,et al.  Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response. , 2010, Current drug delivery.

[6]  D. Scherman,et al.  Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models , 2010, Cancer Gene Therapy.

[7]  S. Wu,et al.  Lipidic Systems for In Vivo siRNA Delivery , 2009, The AAPS Journal.

[8]  D. Scherman,et al.  How to make siRNA lipoplexes efficient? Add a DNA cargo. , 2009, Biochimica et biophysica acta.

[9]  D. Scherman,et al.  Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes. , 2008, Arthritis and rheumatism.

[10]  K. Braeckmans,et al.  A fast and sensitive method for measuring the integrity of siRNA-carrier complexes in full human serum. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Shubiao Zhang,et al.  Cationic lipids and polymers mediated vectors for delivery of siRNA. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Judy Lieberman,et al.  Interfering with disease: a progress report on siRNA-based therapeutics , 2007, Nature Reviews Drug Discovery.

[13]  A. Klippel,et al.  RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy , 2006, Gene Therapy.

[14]  A. Aigner.  Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. , 2006, Journal of biotechnology.

[15]  D. Scherman,et al.  Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis. , 2006, Arthritis and rheumatism.

[16]  B. Williams,et al.  Activation of the mammalian immune system by siRNAs , 2005, Nature Biotechnology.

[17]  Keith Bowman,et al.  Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs , 2005, Nature Biotechnology.

[18]  A. Judge,et al.  Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA , 2005, Nature Biotechnology.

[19]  Matthias John,et al.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.

[20]  R. Macdonald,et al.  DNA release from lipoplexes by anionic lipids: correlation with lipid mesomorphism, interfacial curvature, and membrane fusion. , 2004, Biophysical journal.

[21]  D. Scherman,et al.  A new triantennary galactose-targeted PEGylated gene carrier, characterization of its complex with DNA, and transfection of hepatoma cells. , 2004, Bioconjugate chemistry.

[22]  I. Shih,et al.  Biomedical applications of chemically and microbiologically synthesized poly(glutamic acid) and poly(lysine). , 2004, Mini reviews in medicinal chemistry.

[23]  D. Scherman,et al.  Anionic polyethyleneglycol lipids added to cationic lipoplexes increase their plasmatic circulation time. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[24]  M. Ogris,et al.  PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery , 1999, Gene Therapy.

[25]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[26]  D. Scherman,et al.  Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. , 1998, Biochimica et biophysica acta.

[27]  K. Kiick,et al.  Polysaccharide‐modified synthetic polymeric biomaterials , 2010, Biopolymers.